PUBLISHER: IMARC | PRODUCT CODE: 1746983
PUBLISHER: IMARC | PRODUCT CODE: 1746983
Japan population health management market size reached USD 4.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 25.4 Billion by 2033, exhibiting a growth rate (CAGR) of 20.24% during 2025-2033. The growing prevalence of chronic diseases, such as diabetes, heart disease, and obesity, rising shift towards fee-for-service models to value-based care, and increasing collaborations between insurance companies, hospitals, and physicians represent some of the key factors driving the market.
Population health management (PHM) studies and facilitates care delivery with the objective of improving the health outcomes of a group by monitoring and identifying individual patients within that group. It involves compiling data from various sources, including electronic health records (EHRs), insurance claims, pharmacies, and patient-generated data. It assists healthcare organizations in allocating resources more effectively. It provides information to policymakers on the health status and needs of people to introduce effective health policies. It helps track the spread of diseases and the effectiveness of public health interventions. It identifies at-risk populations proactively and offers preventative care and screenings. It can reduce healthcare costs by preventing expensive interventions like hospital readmissions, through better outpatient care and disease management. It is widely used to manage chronic diseases, such as diabetes, heart disease, and asthma by monitoring patient populations and intervening when needed. Besides this, as it facilitates reducing duplication of services and preventing medical errors, the demand for population health management is increasing across Japan.
The expanding aging population and the escalating demand for healthcare services that cater to chronic and age-related conditions represent one of the primary factors contributing to the market growth in Japan. Additionally, the rising prevalence of chronic diseases, such as diabetes, heart disease, and obesity, is driving the need for effective population health strategies. PHM programs help identify at-risk populations, manage diseases more effectively, and prevent complications through coordinated care. Along with this, the transition from fee-for-service models to value-based care is strengthening the growth of the market in the country. PHM focuses on preventative care, reducing hospital readmissions, and managing chronic diseases, which aids in lowering costs while improving health outcomes. Apart from this, the development of advanced technologies, including EHRs, health information exchanges (HIEs), wearable devices, and telehealth, is offering a favorable market outlook. These technologies enable the collection and analysis of large volumes of health data, facilitating better patient engagement, remote monitoring, and predictive analytics to inform care decisions. Moreover, the increasing collaboration between insurance companies, hospitals, and physicians in Japan to improve health outcomes and reduce costs are facilitating the market growth. This collaboration is often facilitated by PHM systems that integrate payer and provider data to coordinate care and align incentives around patient health. Along with this, the expansion of hospitals, clinics, and other healthcare facilities in the country is facilitating the market growth. In addition, governing authorities of Japan are actively promoting the digitization of healthcare through various initiatives and reforms. These initiatives encourage the development and implementation of PHM solutions, driving the market.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.